2,3-DIBROMOPROPIONALDEHYDE
General Information
Mainterm | 2,3-DIBROMOPROPIONALDEHYDE |
CAS Reg.No.(or other ID) | 5221-17-0 |
Regnum |
176.300 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 92216 |
IUPAC Name | 2,3-dibromopropanal |
InChI | InChI=1S/C3H4Br2O/c4-1-3(5)2-6/h2-3H,1H2 |
InChI Key | ZMDDOWQHSDJXDW-UHFFFAOYSA-N |
Canonical SMILES | C(C(C=O)Br)Br |
Molecular Formula | C3H4Br2O |
Wikipedia | 2,3-dibromopropanal |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 215.872 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 2 |
Complexity | 46.1 |
CACTVS Substructure Key Fingerprint | A A A D c Y B A I A A A G A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g B A A A A B y A C g g A I A A A A A A A A I A A g Q g A A A A A A A A A A A A A E A A C A g A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 17.1 |
Monoisotopic Mass | 213.863 |
Exact Mass | 215.861 |
XLogP3 | None |
XLogP3-AA | 1.3 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 6 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9890 |
Human Intestinal Absorption | HIA+ | 0.9936 |
Caco-2 Permeability | Caco2+ | 0.7293 |
P-glycoprotein Substrate | Non-substrate | 0.8773 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9673 |
Non-inhibitor | 0.9191 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8683 |
Distribution | ||
Subcellular localization | Mitochondria | 0.6231 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8507 |
CYP450 2D6 Substrate | Non-substrate | 0.8055 |
CYP450 3A4 Substrate | Non-substrate | 0.7693 |
CYP450 1A2 Inhibitor | Inhibitor | 0.5236 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9012 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9567 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8218 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9668 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8942 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9688 |
Non-inhibitor | 0.9567 | |
AMES Toxicity | AMES toxic | 0.9896 |
Carcinogens | Carcinogens | 0.7058 |
Fish Toxicity | High FHMT | 0.5780 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9996 |
Honey Bee Toxicity | High HBT | 0.8110 |
Biodegradation | Not ready biodegradable | 0.8176 |
Acute Oral Toxicity | II | 0.6019 |
Carcinogenicity (Three-class) | Non-required | 0.5464 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -0.4768 | LogS |
Caco-2 Permeability | 1.5551 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.9545 | LD50, mol/kg |
Fish Toxicity | 0.1458 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 2.6953 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organic oxygen compounds |
Class | Organooxygen compounds |
Subclass | Carbonyl compounds |
Intermediate Tree Nodes | Aldehydes |
Direct Parent | Alpha-bromoaldehydes |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Alpha-bromoaldehyde - Organic oxide - Hydrocarbon derivative - Organobromide - Organohalogen compound - Alkyl halide - Alkyl bromide - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as alpha-bromoaldehydes. These are aldehydes with the general formula C(Br)C(=O)H, with in which the aldehydic C=O function is conjugated to a C-Br group. |
From ClassyFire